Living evidence in response to controversies about the use of antimalarials in COVID-19

Rev Esp Cardiol (Engl Ed). 2020 Aug;73(8):693-694. doi: 10.1016/j.rec.2020.05.016. Epub 2020 May 29.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antimalarials / adverse effects
  • Antimalarials / therapeutic use*
  • COVID-19
  • Chloroquine / adverse effects
  • Chloroquine / therapeutic use
  • Coronavirus Infections / drug therapy*
  • Humans
  • Hydroxychloroquine / adverse effects
  • Hydroxychloroquine / therapeutic use
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Treatment Outcome

Substances

  • Antimalarials
  • Hydroxychloroquine
  • Chloroquine